Neurotransmitters are essential to your body's intricate neural system. Among them, dopamine stands out for its profound ...

A breakthrough study has uncovered a hidden player in Parkinson’s disease—24-OHC, a cholesterol metabolite that fuels the ...

Researchers at Shanghai Huashan Hospital have identified a novel therapeutic target that could lead to the world's first ...

Researchers suggest drugs that prevent cholesterol from being converted to 24-OHC might therefore be an effective treatment for Parkinson's disease.

Parkinson’s disease may be linked to a cholesterol by-product that helps harmful protein clumps spread in the brain, a ...

Parkinson’s disease is a neurodegenerative disease that causes nerve cells in the brain to die leading to impaired movement, ...

Cambridge researchers are developing implants to help repair brain pathways damaged by Parkinson’s disease. As part of a £69 ...

Approval of Onapgo (apomorphine hydrochloride) marks the first and only subcutaneous apomorphine infusion device for managing motor fluctuations in adults with advanced Parkinson disease.

Her fellowship research focuses on functional imaging in psychogenic movement disorders and her PhD research focuses on Parkinson's disease and ... before PD onset, and dopamine agonist therapy ...

Dr. Raheja highlighted, 'Environmental cues trigger surges in dopamine and glutamate, driving cravings,' reinforcing the need for interventions targeting these pathways. Advances in precision ...

The University of Tasmania will today launch a free Massive Open Online Course (MOOC) on Parkinson's Disease. The course — developed by the University's Wicking Dementia Research and Education ...

and the resulting pulsatile stimulation of dopamine pathways in the brain," said Stuart Isaacson, MD, of the Parkinson's Disease and Movement Disorders Center of Boca Raton in Florida and a ...